House Democrats recently introduced legislation allowing the FDA to reject devices modeled on previous products that were recalled for safety flaws. The agency currently does not have that authority in every case, which can lead to a question in credibility of some approved devices.
The Advanced Medical Technology Association, meanwhile, argued that the proposed bill would add regulatory burdens for manufacturers who already struggle with lengthy FDA reviews.
Related Articles on Supply Chain:
New Michigan Podiatric Group Looks to Contract Directly With Insurers, Vendors
Medical Technology Delegates Go to Washington
Novation Recognizes 25 Suppliers for Excellence in Service
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
